OTHER RECEIVABLES, PREPAYMENTS AND OTHER CURRENT ASSETS, PREPAYMENTS AND OTHER NON - CURRENT ASSETS (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OTHER RECEIVABLES, PREPAYMENTS AND OTHER CURRENT ASSETS, PREPAYMENTS AND OTHER NON - CURRENT ASSETS. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of other receivables |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of prepayments and other current assets |
(1) Other prepayments for research and development expense represents payments made to third party contract research organizations (“CROs”) for pass-through expenses. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of prepayments and other non-current assets |
(2) Other prepayments for research and development expense represents payments made to third party CROs to assist in the performance of clinical trial activities and the contract duration is expected to be 5 years. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||